STOCK TITAN

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Ironwood Pharmaceuticals (Nasdaq: IRWD) has announced its upcoming second quarter 2024 investor update conference call and webcast, scheduled for Thursday, August 8, 2024, at 8:30 a.m. Eastern Time. Interested participants can join via phone or webcast. The call replay will be available until August 22, 2024, and the webcast archive will be accessible on Ironwood's website for one year after the call.

Key details:

  • Conference call-in numbers: (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international)
  • Conference ID and passcode: 2530602
  • Webcast access: Investors section of www.ironwoodpharma.com
  • Replay numbers: (800) 770-2030 (U.S. and Canada) or (609) 800-9909 (international)

Ironwood Pharmaceuticals (Nasdaq: IRWD) ha annunciato la sua prossima videochiamata e diretta streaming per l'aggiornamento agli investitori del secondo trimestre 2024, programmata per giovedì 8 agosto 2024, alle 8:30 ora orientale. I partecipanti interessati possono unirsi tramite telefono o diretta streaming. La registrazione della chiamata sarà disponibile fino al 22 agosto 2024, e l'archivio della diretta sarà accessibile sul sito web di Ironwood per un anno dopo la chiamata.

Dettagli principali:

  • Numeri di accesso per la chiamata: (888) 596-4144 (USA e Canada) o (646) 968-2525 (internazionale)
  • ID conferenza e codice di accesso: 2530602
  • Accesso alla diretta: sezione investitori di www.ironwoodpharma.com
  • Numeri per la registrazione: (800) 770-2030 (USA e Canada) o (609) 800-9909 (internazionale)

Ironwood Pharmaceuticals (Nasdaq: IRWD) ha anunciado su próxima conferencia y transmisión en línea de actualización para inversores del segundo trimestre de 2024, programada para jueves 8 de agosto de 2024, a las 8:30 a.m. Hora del Este. Los participantes interesados pueden unirse por teléfono o por transmisión en línea. La repetición de la llamada estará disponible hasta el 22 de agosto de 2024, y el archivo de la transmisión será accesible en el sitio web de Ironwood durante un año después de la llamada.

Detalles clave:

  • Números de acceso a la conferencia: (888) 596-4144 (EE.UU. y Canadá) o (646) 968-2525 (internacional)
  • ID de conferencia y código de acceso: 2530602
  • Acceso a la transmisión: sección de inversores en www.ironwoodpharma.com
  • Números de repetición: (800) 770-2030 (EE.UU. y Canadá) o (609) 800-9909 (internacional)

아이언우드 제약(Ironwood Pharmaceuticals, Nasdaq: IRWD)은 2024년 2분기 투자자 업데이트 컨퍼런스 콜 및 웹캐스트를 2024년 8월 8일 목요일 오전 8시 30분 (동부 표준시)에 예정하고 있다고 발표했습니다. 관심 있는 참가자는 전화 또는 웹캐스트를 통해 참여할 수 있습니다. 콜 리플레이는 2024년 8월 22일까지 이용 가능하며, 웹캐스트 아카이브는 콜 이후 1년 동안 아이언우드 웹사이트에서 접근할 수 있습니다.

주요 세부사항:

  • 컨퍼런스 콜 연결 번호: (888) 596-4144 (미국 및 캐나다) 또는 (646) 968-2525 (국제)
  • 컨퍼런스 ID 및 비밀번호: 2530602
  • 웹캐스트 접근: www.ironwoodpharma.com 투자자 섹션
  • 리플레이 번호: (800) 770-2030 (미국 및 캐나다) 또는 (609) 800-9909 (국제)

Ironwood Pharmaceuticals (Nasdaq: IRWD) a annoncé sa prochaine conférence téléphonique et webcast de mise à jour pour les investisseurs pour le deuxième trimestre 2024, prévue le jeudi 8 août 2024, à 8h30 heure de l'Est. Les participants intéressés peuvent rejoindre par téléphone ou par webcast. Le replay de l'appel sera disponible jusqu'au 22 août 2024 et l'archive du webcast sera accessible sur le site d'Ironwood pendant un an après l'appel.

Détails clés :

  • Numéros d'appel pour la conférence : (888) 596-4144 (États-Unis et Canada) ou (646) 968-2525 (international)
  • ID de conférence et mot de passe : 2530602
  • Accès au webcast : section investisseurs de www.ironwoodpharma.com
  • Numéros pour le replay : (800) 770-2030 (États-Unis et Canada) ou (609) 800-9909 (international)

Ironwood Pharmaceuticals (Nasdaq: IRWD) hat sein bevorstehendes Investoren-Update für das zweite Quartal 2024 bekannt gegeben, das für Donnerstag, den 8. August 2024, um 8:30 Uhr Eastern Time angesetzt ist. Interessierte Teilnehmer können telefonisch oder über das Webcast teilnehmen. Die Aufzeichnung des Anrufs ist bis zum 22. August 2024 verfügbar, und das Archiv des Webcasts wird ein Jahr nach dem Anruf auf der Website von Ironwood zugänglich sein.

Wichtige Details:

  • Konferenzteilnehmernummern: (888) 596-4144 (USA und Kanada) oder (646) 968-2525 (international)
  • Konferenz-ID und Passwort: 2530602
  • Zugang zum Webcast: Investorenbereich von www.ironwoodpharma.com
  • Wiederholungsnummern: (800) 770-2030 (USA und Kanada) oder (609) 800-9909 (international)
Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 8, 2024. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID number and event passcode 2530602. To access the webcast, please visit the Investors section of Ironwood’s website at www.ironwoodpharma.com.

The call will be available for replay via telephone starting Thursday, August 8, 2024 at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on Thursday, August 22, 2024. To listen to the replay, dial (800) 770-2030 (U.S. and Canada) or (609) 800-9909 (international) using conference ID number 2530602. The archived webcast will be available on Ironwood’s website for 1 year beginning approximately one hour after the call has completed.

About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years-old. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.

Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, with a site in Basel, Switzerland.

We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn.

Investors:

Greg Martini, 617-374-5230

gmartini@ironwoodpharma.com

Matt Roache, 617-621-8395

mroache@ironwoodpharma.com

Media:

Beth Calitri, 978-417-2031

bcalitri@ironwoodpharma.com

Source: Ironwood Pharmaceuticals, Inc.

FAQ

When is Ironwood Pharmaceuticals (IRWD) hosting its Q2 2024 investor update call?

Ironwood Pharmaceuticals (IRWD) is hosting its Q2 2024 investor update call on Thursday, August 8, 2024, at 8:30 a.m. Eastern Time.

How can investors access Ironwood Pharmaceuticals' (IRWD) Q2 2024 earnings call?

Investors can access Ironwood Pharmaceuticals' (IRWD) Q2 2024 earnings call by dialing (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID 2530602, or via webcast on the company's website.

Until when will the replay of Ironwood Pharmaceuticals' (IRWD) Q2 2024 earnings call be available?

The replay of Ironwood Pharmaceuticals' (IRWD) Q2 2024 earnings call will be available until 11:59 p.m. Eastern Time on Thursday, August 22, 2024.

Where can I find the archived webcast of Ironwood Pharmaceuticals' (IRWD) Q2 2024 earnings call?

The archived webcast of Ironwood Pharmaceuticals' (IRWD) Q2 2024 earnings call will be available on the company's website at www.ironwoodpharma.com for one year after the call.

Ironwood Pharmaceuticals, Inc. -

NASDAQ:IRWD

IRWD Rankings

IRWD Latest News

IRWD Stock Data

677.53M
159.74M
1.69%
109.68%
9.89%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BOSTON